André Furco

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

CD4+ Count–Guided Interruption of Antiretroviral Treatment

The Effect of Lopinavir/Ritonavir on the Renal Clearance of Tenofovir in HIV-infected Patients

The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy

Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?

Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV

The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists

Association of tenofovir exposure with kidney disease risk in HIV infection

The end of AIDS: HIV infection as a chronic disease

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients

The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years

Tenofovir-Associated Acute and Chronic Kidney Disease: A Case of Multiple Drug Interactions

Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA

Antiretroviral Treatment of Adult HIV Infection

The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

Tenofovir‐Related Nephrotoxicity in Human Immunodeficiency Virus–Infected Patients: Three Cases of Renal Failure, Fanconi Syndrome, and Nephrogenic Diabetes Insipidus